Related Experiment Videos
[Acetylsalicylic acid in pregnancy]
H Karas1, C Egarter, P Husslein
1I. Universitäts-Frauenklinik, Wien.
Wiener Klinische Wochenschrift
|January 1, 1993
Summary
Low-dose aspirin can safely reduce preeclampsia incidence in high-risk pregnancies by correcting thromboxane A2 imbalances. It is not recommended for treating existing preeclampsia or preventing premature labor.
Area of Science:
- Obstetrics and Gynecology
- Pharmacology
Context:
- Preeclampsia involves a prostacyclin/thromboxane A2 imbalance.
- Thromboxane A2 increase contributes to preeclampsia pathophysiology.
Purpose:
- To evaluate the efficacy and safety of low-dose aspirin in managing preeclampsia.
- To determine aspirin's role in preventing preeclampsia and intrauterine growth retardation.
Summary:
- Low-dose aspirin corrects elevated thromboxane A2 levels without reducing prostacyclin.
- Clinical trials show aspirin is effective in preventing preeclampsia and intrauterine growth retardation in high-risk women.
- Aspirin is not recommended for treating established preeclampsia or preventing preterm labor.
Impact:
- Low-dose aspirin offers a safe and effective preventative strategy for preeclampsia in select high-risk populations.
- Further research is needed to assess aspirin's efficacy in recurrent spontaneous abortion.